Riskpilot← Back to searchSign inGet full accessJulianska AB
ABActiveOrg 5592009608Kristinelundsgatan 1Medical specialists activities · NACE 8622Est. 20192 employees
Revenue 2025
SEK 1,1M
+56% vs 2024
EBITDA margin
10.9%
-72% vs 2024
Equity ratio
26.2%
Financial strength
Net profit 2025
SEK 90K
-73% vs 2024
| Revenue | SEK 1,1M | +56% |
| EBITDA | SEK 118K | -72% |
| Net profit | SEK 90K | -73% |
| Total assets | SEK 573K | -9% |
| Equity | SEK 150K | -62% |
| Employees | 2 | — |
Legal name
Julianska AB
Org number
5592009608
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
1 april 2019
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva sjukvårds- och läkartjänster samt även bedriva konsultationer till både öppenvård och slutenvård samt därmed förenlig verksamhet. Vidare bedriver bolaget även föredragsverksamhet på konsultbasis, föredrag hålls inom ämne sjukvård, hygien, kirurgi, smärta och inom därmed förenliga områden. Därtill skall bolaget även bedriva kapitalförvaltning samt därmed förenlig verksamhet.
Address
Kristinelundsgatan 1
Email
abdi.hersi@julianska.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7 127 | −226 | 591 | 693 | 1 081 |
| Staff expenses | — | −222 | 15 | 62 | — |
| EBITDA | 1 084 | −687 | 466 | 429 | 118 |
| Depreciation & amort. | −0 | — | — | — | −0 |
| EBIT | 1 084 | −687 | 466 | 429 | 118 |
| Net financials | — | −13 | −16 | −1 | — |
| Profit before tax | 930 | −480 | 450 | 428 | 117 |
| Tax | −193 | — | −1 | −94 | −27 |
| Net profit | 737 | −480 | 449 | 334 | 90 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 189 | 177 | 518 | 632 | 573 |
| Equity | 787 | −109 | 340 | 394 | 150 |
| Long-term debt | 0 | — | — | — | 0 |
| Short-term debt | 1 182 | 286 | 178 | 238 | 422 |
| Total debt | 1 182 | 286 | 178 | 238 | 422 |
EBITDA margin
10.9%
This company
15.8%
Market median
-31% vs market
20212025
Equity ratio
26.2%
This company
38.2%
Market median
-31% vs market
20212025
Return on equity
60.0%
This company
18.4%
Market median
+226% vs market
20212025
Net profit margin
8.3%
This company
8.1%
Market median
+2% vs market
20212025
Asset turnover
1.89×
This company
1.12×
Market median
+69% vs market
20212025
Debt / equity
2.82×
This company
0.62×
Market median
-355% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Julianska AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fuad Hersi | Deputy Board Member | 0 companies |
| Abdi-Fatah Hersi | Board of Directors | 0 companies |